Ketamine helps a third of patients with treatment resistant depression, finds small UK study

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Torjesen, Ingrid ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE;

ANTERIOR CINGULATE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BLADDER DISEASE; COGNITIVE DEFECT; CONFUSION; DRUG SAFETY; DRUG WITHDRAWAL; FAINTNESS; FATIGUE; HEADACHE; HUMAN; NAUSEA; PANIC; PERCEPTION DISORDER; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT RESISTANT DEPRESSION; VOMITING;

ADMINISTRATION, INTRAVENOUS; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS; KETAMINE;

EID: 84897982929     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g2576     Document Type: Article

References (2)

1. Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 2013;170:1134-42.
2. Diamond PR, Farmery AD, Atkinson S, Haldar J, Williams N, Cowen PJ, et al. Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic. J Psychopharmacol 3 Apr 2014 doi:10.1177/ 0269881114527361